Mergers & Acquisitions

Investments Mergers and Acquisitions Private Equity Corporate Finance Corporate Finance Corporate Strategy Mergers and Acquisitions Acquisitions Regulatory Approvals Ownership

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.

Phil Rogers to Succeed Lars Wingefors as Embracer Group CEO

L'Oreal Takes Majority Stake in British Skincare Brand Medik8

McMahon Offloads $250 Million in TKO Shares as Endeavor’s Stake Climbs to 61.7%

CAA Adds Brent Weinstein to Lead Digital and Data Divisions

Hudson’s Bay Secures Creditor Protection Extension and Begins Debt Repayment

Paul Allen Estate Officially Begins Sale of Portland Trail Blazers

TKO Group Exceeds Q1 Earnings Expectations and Raises 2025 Guidance

Vodafone CFO Luka Mucic to Depart as UK-Three Merger Nears Completion

Ari Emanuel Acquires Frieze From Endeavor to Launch New Events Company

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

DoorDash Proposes $3.6 Billion Acquisition of UK Rival Deliveroo

TKO Group Discloses Executive Pay as Media Deals and WrestleMania Records Drive Growth

MSG Networks Finalizes $804M Debt Restructuring and Media Rights Cuts

Fort Point and HenHouse Merge to Create Bay Area Brewery Powerhouse

Paramount and Skydance Merger Extended 90 Days as FCC Approval Remains Pending

Haldiram Secures $10 Billion Valuation with Minority Investments from IHC, Alpha Wave, and Temasek

Greencore Reaches £1.2 Billion Agreement to Acquire Bakkavor

ITV Studios Acquires Majority Stake in Moonage Pictures

Pfizer Completes £2.5 Billion Sale of Remaining Stake in Haleon